新型脂質(zhì)-HAP-DNA復(fù)合體用于基因轉(zhuǎn)染研究
發(fā)布時間：2018-08-05 19:23
【摘要】：基因治療是將基因?qū)肴梭w細胞中,以期產(chǎn)生有益的蛋白質(zhì)來治療疾病的一種方法。1995年,美國國立衛(wèi)生組織(NIH)提出基因治療目前存在的三大關(guān)鍵問題之重點問題便是:具有良好選擇性、安全性和高效性的基因?qū)胂到y(tǒng)(即基因載體)。非病毒載體由于具有低毒,低免疫反應(yīng),靶向性和易于組裝等優(yōu)點,但轉(zhuǎn)染效率一直不高。如何提高DNA在基因轉(zhuǎn)染和基因治療中的轉(zhuǎn)染效率成為-基因轉(zhuǎn)導(dǎo)技術(shù)的關(guān)鍵問題。因此尋找新的非病毒載體成為目前的研究熱點。 本研究自行組裝構(gòu)建了一種新型非病毒基因載體脂質(zhì)-HAP-DNA復(fù)合體(Lipid—Hydroxyapatite—DNA,LHD)并驗證其用作基因轉(zhuǎn)導(dǎo)的可行性。本論文分為三個部分: 第一研究了HAP納米粒子的制備與改性。通過該部分研究我們得到如下結(jié)論: 1.運用化學(xué)沉淀法合成了HAP納米顆粒并進行了表面改性。得到了Ca/P比接近1.67的HAP納米顆粒,在緩沖液中穩(wěn)定性及分散性良好、粒徑均勻、符合下一步研究需要。 2.利用有機大分子A作為穩(wěn)定劑,改性后HAP表面Zeta電位為正,在緩沖液中可長時間穩(wěn)定存在。 3.化學(xué)沉淀法合成納米HAP時,反應(yīng)溫度、PH值對產(chǎn)物HAP的影響顯著,溶液濃度對產(chǎn)物HAP影響不大。 4.超聲處理、滴加速度及攪拌強度作為輔助手段會對制備所得納米HAP晶體尺寸產(chǎn)生影響,而穩(wěn)定劑種類和劑量會顯著影響生成納米HAP的表面特性。 第二進行了LHD復(fù)合體的制備研究。得到如下結(jié)論: 1.用正電荷的納米HAP分別與不同比例的DNA結(jié)合,最終確定b DNA與HAP的較為合適的結(jié)合比例。 2.用反相蒸發(fā)法將DNA—HAP復(fù)合物包裹進入脂質(zhì)膜中,制備得到LHD復(fù)合體。觀察到合成的LHD復(fù)合體成球形、具有一定包封率,并且對被包裹的DNA起到有效的保護作用。 3.在LHD復(fù)合體的制備中,進行了溫度變化和光線照射對卵磷脂氧化率和LHD的包封率的影響的研究。確定了實驗的防氧化措施及貯存方法。
[Abstract]:Gene therapy is a method of introducing genes into human cells in order to produce beneficial proteins to treat diseases. The National Health Organization (NIH) has put forward three key problems in gene therapy: a gene transfer system (gene vector) with good selectivity, safety and efficiency. Non-viral vectors have the advantages of low toxicity, low immune response, targeting and easy assembly, but the transfection efficiency is not high. How to improve the transfection efficiency of DNA in gene transfection and gene therapy has become a key issue in gene transduction technology. Therefore, the search for new non-viral vectors has become a hot research topic. A novel non-viral gene vector lipid-HAP-DNA complex (Lipid-Hydroxyapatite-DNA LHD) was constructed and its feasibility for gene transduction was verified. This thesis is divided into three parts: firstly, the preparation and modification of HAP nanoparticles are studied. Through this part of the study, we get the following conclusions: 1. HAP nanoparticles were synthesized and modified by chemical precipitation method. The HAP nanoparticles with Ca/P ratio close to 1.67 have good stability and dispersion in buffer solution, and the particle size is uniform, which meets the need of further study. Using organic macromolecule A as stabilizer, the surface Zeta potential of modified HAP is positive, which can be stabilized in buffer solution for a long time. In the synthesis of nanometer HAP by chemical precipitation method, the pH value of the reaction temperature has a significant effect on the product HAP, while the concentration of solution has little effect on the product HAP. Ultrasonic treatment, drop acceleration and stirring intensity as auxiliary means will affect the size of the prepared nanocrystalline HAP crystal, and the type and dosage of stabilizer will significantly affect the surface characteristics of the nanocrystalline HAP. Secondly, the preparation of LHD complex was studied. The conclusions are as follows: 1. The proper binding ratio of b DNA and HAP was determined by combining positive charge nanometer HAP with different proportion of DNA respectively. The DNA-HAP complex was encapsulated into the lipid membrane by reversed-phase evaporation to prepare the LHD complex. It is observed that the synthesized LHD complex is spherical, has a certain encapsulation efficiency and has an effective protective effect on the encapsulated DNA. In the preparation of LHD complex, the effects of temperature and light irradiation on the oxidation rate of lecithin and the encapsulation efficiency of LHD were studied. The anti-oxidation measures and storage methods are determined.
【學(xué)位授予單位】：武漢理工大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2005
【分類號】：R346
本文編號：2166756
[Abstract]:Gene therapy is a method of introducing genes into human cells in order to produce beneficial proteins to treat diseases. The National Health Organization (NIH) has put forward three key problems in gene therapy: a gene transfer system (gene vector) with good selectivity, safety and efficiency. Non-viral vectors have the advantages of low toxicity, low immune response, targeting and easy assembly, but the transfection efficiency is not high. How to improve the transfection efficiency of DNA in gene transfection and gene therapy has become a key issue in gene transduction technology. Therefore, the search for new non-viral vectors has become a hot research topic. A novel non-viral gene vector lipid-HAP-DNA complex (Lipid-Hydroxyapatite-DNA LHD) was constructed and its feasibility for gene transduction was verified. This thesis is divided into three parts: firstly, the preparation and modification of HAP nanoparticles are studied. Through this part of the study, we get the following conclusions: 1. HAP nanoparticles were synthesized and modified by chemical precipitation method. The HAP nanoparticles with Ca/P ratio close to 1.67 have good stability and dispersion in buffer solution, and the particle size is uniform, which meets the need of further study. Using organic macromolecule A as stabilizer, the surface Zeta potential of modified HAP is positive, which can be stabilized in buffer solution for a long time. In the synthesis of nanometer HAP by chemical precipitation method, the pH value of the reaction temperature has a significant effect on the product HAP, while the concentration of solution has little effect on the product HAP. Ultrasonic treatment, drop acceleration and stirring intensity as auxiliary means will affect the size of the prepared nanocrystalline HAP crystal, and the type and dosage of stabilizer will significantly affect the surface characteristics of the nanocrystalline HAP. Secondly, the preparation of LHD complex was studied. The conclusions are as follows: 1. The proper binding ratio of b DNA and HAP was determined by combining positive charge nanometer HAP with different proportion of DNA respectively. The DNA-HAP complex was encapsulated into the lipid membrane by reversed-phase evaporation to prepare the LHD complex. It is observed that the synthesized LHD complex is spherical, has a certain encapsulation efficiency and has an effective protective effect on the encapsulated DNA. In the preparation of LHD complex, the effects of temperature and light irradiation on the oxidation rate of lecithin and the encapsulation efficiency of LHD were studied. The anti-oxidation measures and storage methods are determined.
【學(xué)位授予單位】：武漢理工大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2005
【分類號】：R346
【參考文獻】
相關(guān)期刊論文 前6條
1 王學(xué)江,汪建新,李玉寶,馮健清,嚴永剛,黃玫,楊愛萍;常壓下納米級羥基磷灰石針狀晶體的合成[J];高技術(shù)通訊;2000年11期
2 沈衛(wèi),顧燕芳,劉昌勝,孫祥明,胡黎明;羥基磷灰石的表面特性[J];硅酸鹽通報;1996年01期
3 何曉曉,王柯敏,譚蔚泓,劉斌,林霞,黃杉生,李杜,何春梅,李軍;基于氨基化SiO_2納米顆粒的新型基因載體[J];科學(xué)通報;2002年18期
4 曹恩華，劉曉麒，朱曰榮;脂質(zhì)體過氧化對DNA的損傷研究[J];生物物理學(xué)報;1994年01期
5 郭連峰,張文光,王成燾;納米羥基磷灰石的制備及結(jié)晶尺寸的控制[J];無機化學(xué)學(xué)報;2004年03期
6 袁媛,劉昌勝;溶膠-凝膠法制備納米羥基磷灰石[J];中國醫(yī)學(xué)科學(xué)院學(xué)報;2002年02期
，本文編號：2166756
本文鏈接：http://sikaile.net/yixuelunwen/binglixuelunwen/2166756.html
最近更新
教材專著
